P

Inventor

QIAN YIMIN

US75 patents
⚠️ This page may combine multiple inventors who share the name “QIAN YIMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARVINAS OPERATIONS INC

19 patents
US11104666B2Aug 31, 2021

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC18 citations94
US10899742B1Jan 26, 2021

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC18 citations94
US11597720B2Mar 7, 2023

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC4 citations86
US11384063B2Jul 12, 2022

Modulators of estrogen receptor proteolysis and associated methods of use

ARVINAS OPERATIONS INC2 citations73
US11191741B2Dec 7, 2021

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

ARVINAS OPERATIONS INC3 citations73
US11427548B2Aug 30, 2022

Compounds and methods for the targeted degradation of androgen receptor

ARVINAS OPERATIONS INC2 citations72
US12577255B2Mar 17, 2026

MDM2-based modulators of proteolysis and associated methods of use

ARVINAS OPERATIONS INC0 citations62
US12312316B2May 27, 2025

Compounds and methods for the targeted degradation of androgen receptor

ARVINAS OPERATIONS INC0 citations62
US12275716B2Apr 15, 2025

Modulators of estrogen receptor proteolysis and associated methods of use

ARVINAS OPERATIONS INC0 citations62
US12239711B2Mar 4, 2025

Cereblon ligands and bifunctional compounds comprising the same

ARVINAS OPERATIONS INC0 citations62
US12171831B2Dec 24, 2024

Compounds and methods for the targeted degradation of bromodomain- containing proteins

ARVINAS OPERATIONS INC0 citations62
US12172981B2Dec 24, 2024

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC0 citations62
US11857519B2Jan 2, 2024

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

ARVINAS OPERATIONS INC0 citations62
US11554171B2Jan 17, 2023

Compounds and methods for the targeted degradation of bromodomain-containing proteins

ARVINAS OPERATIONS INC0 citations62
US10946017B2Mar 16, 2021

Tank-binding kinase-1 PROTACs and associated methods of use

ARVINAS OPERATIONS INC0 citations62
US10865202B2Dec 15, 2020

Indole derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC1 citations62
US12264157B2Apr 1, 2025

Compounds and methods for the enhanced degradation of targeted proteins

ARVINAS OPERATIONS INC0 citations61
US11512083B2Nov 29, 2022

Compounds and methods for the enhanced degradation of targeted proteins

ARVINAS OPERATIONS INC1 citations61
US11584743B2Feb 21, 2023

Indole derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC0 citations58

HOFFMANN LA ROCHE

8 patents

ACCUTAR BIOTECHNOLOGY INC

7 patents

ARVINAS INC

6 patents

BOLIN DAVID ROBERT

4 patents

MERCK SHARP & DOHME

2 patents

TIGER BIOTHERAPEUTICS INC

2 patents

VIA PHARMACEUTICALS INC

1 patent

Accutar Biotechnology

1 patent

Showing the top 50 of 75 patents by PatentIndex Score.